Back

Cardiovascular implications of CAR-T cell therapy: insights from a regional cardio-oncology program

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: new drugs, new challenges Diagnosis and Management of Cardiovascular Disease in Patients with Cancer ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Federico Guerra

Marche Polytechnic University of Ancona, Ancona (Italy)

6 More presentations in this session

Presentation thumbnail
The cardioprotective effect of inhibitor sodium glucose transporter in patients undergoing chemotherapy: a systematic review and meta-analysis
Mr J. Peres De Oliveira (BR)
Abstract Slides Video
Presentation thumbnail
Influence of the 3-omega fatty acids supplementation on the structure, regulation and vascular function of rats chronically treated with doxorubicin
Ms M. Gaiato Monte (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of TAVI in patients with active cancer: a bridge to success?
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Meta-analysis and predictors of cancer therapy-related right ventricular dysfunction: insights from FAC measurements
Doctor C. Fischer Bacca (Rio do Sul, BR)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: a meta-analysis of efficacy and safety outcomes
Doctor K. Hosseini (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Cardio-oncology: new drugs, new challenges

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Patients with non-Hodgkin's lymphoma treated with CAR T-cell therapy are at risk of impaired left ventricular function
thumbnail
Congress Presentation
Cardiovascular magnetic resonance vs. echocardiography for assessing baseline cardiovascular reserve in patients undergoing CAR-T therapy
thumbnail
Congress Presentation
Predictive factors and baseline risk stratification for CAR-T cell therapy-related cardiovascular toxicity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources